Am. J. Respir. Crit. Care Med.,
Volume 163, Number 7, June 2001, 1676-1682
Long-term Inhalation of High-dose Nitric Oxide
Increases Intraalveolar Activation of Coagulation
System in Mice
TETSU
KOBAYASHI,
ESTEBAN C.
GABAZZA,
SHINO
SHIMIZU,
HIROKI
YASUI,
HISAMICHI
YUDA,
OSAMU
HATAJI,
KAZUO
MARUYAMA,
TORU
YAMAUCHI,
KOJI
SUZUKI,
YUKIHIKO
ADACHI,
and
OSAMU
TAGUCHI
Third Department of Internal Medicine, Department of Molecular Pathobiology, Department of Anesthesiology, and Department of Public
Hygiene, Mie University School of Medicine, Tsu, Mie, Japan
Inhalation of nitric oxide (NO) is useful for the treatment of patients with pulmonary hypertension. However, the potential toxicity of inhaled NO is still unclear. Coagulation activation plays an
important role in lung injury. We assessed the effect of low- and
high-dose inhaled NO on the coagulation system in the intraalveolar space of mice. The animals were assigned to five groups (n = 6):
[RA] group, mice exposed to fresh air alone; [RA+2 ppm NO] group,
fresh air and 2 ppm NO; [RA+40 ppm NO] group, fresh air and
40 ppm NO; [RA+2 ppm NO+O2] group, fresh air, 2 ppm NO and O2;
and [RA+40 ppm NO+O2] group, fresh air, 40 ppm NO and O2.
Each group was treated for 3 wk. Lung specimens of [RA+40 ppm
NO] and [RA+40 ppm NO+O2] groups showed significant nitrotyrosine immunoreactivity. BALF concentrations of total protein, thrombin and soluble tissue factor were significantly increased in
mice of [RA+40 ppm NO] and [RA+40 ppm NO+O2] groups compared with [RA] group. However, BALF concentrations of total
protein, thrombin, and soluble tissue factor were not significantly
increased in mice of [RA+2 ppm NO] and [RA+2 ppm NO+O2]
groups compared with [RA] group. Lung tissue factor mRNA expression was higher in the high-dose NO group than in the low-dose NO group. NO donor increased significantly tissue factor activity on alveolar epithelial cells. This study has shown for the first
time that long-term inhalation of high, but not low, concentration
of NO may activate the clotting system by increasing the lung expression of tissue factor.